First Ebola Case in U.S. Keeps the Ebola Trade Rolling
Insights - Just after the close on Tuesday the United States’ Centers for Disease Control and Prevention (CDC) confirmed the first infection of Ebola Zaire in a … Continue Reading
Read NowRecap
The Liver is Hot in Biotech. All Eyes on November
Recap - November is approaching, and the AASLD’s Liver Meeting conference the second week of the month, attracting a bevy of investors this year. The liver has become … Continue Reading
Read Now
Cempra’s Phase 3 Trial Enrolled Faster than Expected
Insights - Cempra, Inc. (CEMP) enrolled patients in SOLITAIRE-Oral, a phase 3 trial of lead antibiotic solithromycin, slightly faster than expected, announcing completion on Thursday that puts a … Continue Reading
Read NowIt’s Time to Revisit this Shareholder-Friendly Biotech Company
Recap - Auxilium Pharmaceuticals (AUXL) was approached by Endo Pharmaceuticals (ENDP) this week in a $2.2 billion unsolicited acquisition attempt. The stock and cash deal would represent … Continue Reading
Read NowPropThink’s Weekly Biotech Roundup
Recap - A dual event in the obesity space this week, the U.S. FDA approved Orexigen Therapeutics’ (OREX) weight loss pill Contrave just one day before an … Continue Reading
Read NowTrading Biotech Stocks Around FDA Approval Decisions Is Rarely Cut and Dry
Biotechnology Stocks are Making New All-Time Highs
Recap - Six weeks after Federal Reserve Chairwoman Janet Yellen called biotechnology valuations “substantially stretched” the NASDAQ Biotechnology Index (IBB) is setting new records right alongside the S&P 500. It’s … Continue Reading
Read Now